排序方式: 共有25条查询结果,搜索用时 15 毫秒
1.
Giovanni Barone‐Adesi Marinela Adriana Finta Chiara Legnazzi Carlo Sala 《Journal of forecasting》2019,38(6):552-563
Using option market data we derive naturally forward‐looking, nonparametric and model‐free risk estimates, three desired characteristics hardly obtainable using historical returns. The option‐implied measures are only based on the first derivative of the option price with respect to the strike price, bypassing the difficult task of estimating the tail of the return distribution. We estimate and backtest the 1%, 2.5%, and 5% WTI crude oil futures option‐implied value at risk and conditional value at risk for the turbulent years 2011–2016 and for both tails of the distribution. Compared with risk estimations based on the filtered historical simulation methodology, our results show that the option‐implied risk metrics are valid alternatives to the statistically based historical models. 相似文献
2.
3.
Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. 总被引:11,自引:0,他引:11
Michael G Anderson Richard S Smith Norman L Hawes Adriana Zabaleta Bo Chang Janey L Wiggs Simon W M John 《Nature genetics》2002,30(1):81-85
Pigmentary glaucoma is a significant cause of human blindness. Abnormally liberated iris pigment and cell debris enter the ocular drainage structures, leading to increased intraocular pressure (IOP) and glaucoma. DBA/2J (D2) mice develop a form of pigmentary glaucoma involving iris pigment dispersion (IPD) and iris stromal atrophy (ISA). Using high-resolution mapping techniques, sequencing and functional genetic tests, we show that IPD and ISA result from mutations in related genes encoding melanosomal proteins. IPD is caused by a premature stop codon mutation in the Gpnmb (GpnmbR150X) gene, as proved by the occurrence of IPD only in D2 mice that are homozygous with respect to GpnmbR150X; otherwise, similar D2 mice that are not homozygous for GpnmbR150X do not develop IPD. ISA is caused by the recessive Tyrp1b mutant allele and rescued by the transgenic introduction of wildtype Tyrp1. We hypothesize that IPD and ISA alter melanosomes, allowing toxic intermediates of pigment production to leak from melanosomes, causing iris disease and subsequent pigmentary glaucoma. This is supported by the rescue of IPD and ISA in D2 eyes with substantially decreased pigment production. These data indicate that pigment production and mutant melanosomal protein genes may contribute to human pigmentary glaucoma. The fact that hypopigmentation profoundly alleviates the D2 disease indicates that therapeutic strategies designed to decrease pigment production may be beneficial in human pigmentary glaucoma. 相似文献
4.
Resumen En el presente trabajo se estudia el efecto del hipotiroidismo sobre la sintesis de DNA y proliferación celular renal estimuladas por isoproterenol. Se observa que la hormona tiroidea actúa como intermediario de las catecolaminas en el proceso de multiplicación celular. Se sugiere que la hormona tiroidea modula el efecto de catecolaminas aumentando la sensibilidad en el receptor. El aumento de la concentración de cAMP podría estar involucrado en este proceso.
This work was supported by a grant from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Rep. Argentina. 相似文献
This work was supported by a grant from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Rep. Argentina. 相似文献
5.
6.
7.
8.
9.
A. Simonetti S. Marzi L. Jenner A. Myasnikov P. Romby G. Yusupova B. P. Klaholz M. Yusupov 《Cellular and molecular life sciences : CMLS》2009,66(3):423-436
The assembly of the protein synthesis machinery occurs during translation initiation. In bacteria, this process involves the
binding of messenger RNA(mRNA) start site and fMet-tRNAfMet to the ribosome, which results in the formation of the first codon-anticodon interaction and sets the reading frame for the
decoding of the mRNA. This interaction takes place in the peptidyl site of the 30S ribosomal subunit and is controlled by
the initiation factors IF1, IF2 and IF3 to form the 30S initiation complex. The binding of the 50S subunit and the ejection
of the IFs mark the irreversible transition to the elongation phase. Visualization of these ligands on the ribosome has been
achieved by cryo-electron microscopy and X-ray crystallography studies, which has helped to understand the mechanism of translation
initiation at the molecular level. Conformational changes associated with different functional states provide a dynamic view
of the initiation process and of its regulation.
Received 16 July 2008; received after revision 31 August 2008; accepted 10 September 2008
A. Simonetti, S. Marzid: These authors contributed equally to this work. 相似文献
10.
Yusa K Rashid ST Strick-Marchand H Varela I Liu PQ Paschon DE Miranda E Ordóñez A Hannan NR Rouhani FJ Darche S Alexander G Marciniak SJ Fusaki N Hasegawa M Holmes MC Di Santo JP Lomas DA Bradley A Vallier L 《Nature》2011,478(7369):391-394
Human induced pluripotent stem cells (iPSCs) represent a unique opportunity for regenerative medicine because they offer the prospect of generating unlimited quantities of cells for autologous transplantation, with potential application in treatments for a broad range of disorders. However, the use of human iPSCs in the context of genetically inherited human disease will require the correction of disease-causing mutations in a manner that is fully compatible with clinical applications. The methods currently available, such as homologous recombination, lack the necessary efficiency and also leave residual sequences in the targeted genome. Therefore, the development of new approaches to edit the mammalian genome is a prerequisite to delivering the clinical promise of human iPSCs. Here we show that a combination of zinc finger nucleases (ZFNs) and piggyBac technology in human iPSCs can achieve biallelic correction of a point mutation (Glu342Lys) in the α(1)-antitrypsin (A1AT, also known as SERPINA1) gene that is responsible for α(1)-antitrypsin deficiency. Genetic correction of human iPSCs restored the structure and function of A1AT in subsequently derived liver cells in vitro and in vivo. This approach is significantly more efficient than any other gene-targeting technology that is currently available and crucially prevents contamination of the host genome with residual non-human sequences. Our results provide the first proof of principle, to our knowledge, for the potential of combining human iPSCs with genetic correction to generate clinically relevant cells for autologous cell-based therapies. 相似文献